Clinical Trial Update: Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix™ (Human Rotavirus Vaccine) in Indian Infants

View source ↗

Summary

Completed clinical trial assessing reactogenicity and safety of Rotarix rotavirus vaccine in Indian infants with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Gastroenteritis
• Rotavirus Infection

Drugs mentioned

• Rotarix (Rotavirus vaccine (live attenuated))

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Rotavirus | Status: COMPLETED | Results posted: 2011-03-16